Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

CAR2.0 Therapy for the Management of Post-Transplantation Relapse of B-Cell Acute Lymphoblastic Leukemia

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141531

Published: 2020

Journal Articles

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, PhD, Lujia Dong, MD, Yu-Chen Liu, MSc, Shih-Ting Tsao, MSc, Ya-Chen Li, PhD, Li Liu, MD, Zhiyong Gao, MD, Xiyou Tan, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, Jing-Bo Wang, Yu-Ming Ying, MD, Le-Ping Zhang, MD, Huyong Zheng, MD PhD, Kai Wang, MD PhD, Xiao-Li Zheng, MD, Heng-Xiang Wang, MD, Xun Lai, MD, Dong Li, MD

Blood (2016) 128 (22): 587.

https://doi.org/10.1182/blood.V128.22.587.587

Published: 2016

Journal Articles

High-Throughput Mutational Profiling Of Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia Reveals Frequent Mutations In NRAS In JAK2 V617F-Negative Post-MPN AML

Raajit K. Rampal, M.D., Ph.D, Sean M. Devlin, PhD, Anna Sophia Mckenney, B.S. M.P.H., Kristina M. Knapp, BS, Minal Patel, Kai Wang, MD PhD, Michelle K. Nahas, PhD, Roman Yelensky, PhD, Geoff A. Otto, PhD, Doron Lipson, PhD, Philip J. Stephens, PhD, Vincent A. Miller, MD, Taghi Manshouri, Ph.D., Srdan Verstovsek, MD, PhD, Ross L. Levine, MD

Blood (2013) 122 (21): 4098.

https://doi.org/10.1182/blood.V122.21.4098.4098

Published: 2013

Journal Articles

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Alan M Hanash, MD, PhD, Sean M. Devlin, PhD, Molly Maloy, MA, Kristina M. Knapp, BS, Vincent A. Miller, MD, Doron Lipson, PhD, Philip J. Stephens, PhD, Geoff A Otto, PhD, Roman Yelensky, PhD, Michelle K. Nahas, PhD, Kai Wang, MD PhD, Ross L. Levine, MD, Marcel R.M. van den Brink, MD, PhD, Ann A. Jakubowski, MD, PhD

Blood (2013) 122 (21): 2096.

https://doi.org/10.1182/blood.V122.21.2096.2096

Published: 2013

Journal Articles

Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms

Raajit K. Rampal, M.D., Ph.D., Sean M. Devlin, PhD, Jay P. Patel, Kristina M. Knapp, BS, Minal Patel, Joel R Greenbowe, BS, Lauren E Young, MS, Jie He, PhD, Kai Wang, MD PhD, Michelle K. Nahas, PhD, Roman Yelensky, PhD, Geoff A. Otto, PhD, Doron Lipson, PhD, Philip J. Stephens, PhD, Vincent A. Miller, MD, Ross L. Levine, MD

Blood (2013) 122 (21): 1588.

https://doi.org/10.1182/blood.V122.21.1588.1588

Published: 2013

Journal Articles

Comprehensive Mutational Profiling In Myelodysplastic Syndromes Treated With Decitabine and Tretinoin

Alan H. Shih, MD PhD, Sean M. Devlin, PhD, Emily K. Dolezal, Kristina M. Knapp, BS, Kai Wang, MD PhD, Eric M. Sanford, BS, Tim Brennan, PhD, Roman Yelensky, PhD, Michelle Nahas, PhD, Geoff A Otto, PhD, Doron Lipson, PhD, Philip J Stephens, PhD, Vincent Miller, MD, Marcel R.M. van den Brink, MD, PhD, Ross L. Levine, MD, Stephen Nimer, MD, Virginia M. Klimek, M.D

Blood (2013) 122 (21): 2791.

https://doi.org/10.1182/blood.V122.21.2791.2791

Published: 2013

Journal Articles

Patient Derived Xenograft (PDX) Models Faithfully Recapitulate The Genetic Composition Of Primary AML

Blood (2013) 122 (21): 1328.

https://doi.org/10.1182/blood.V122.21.1328.1328

Published: 2013

Journal Articles

Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma

Blood (2013) 122 (21): 755.

https://doi.org/10.1182/blood.V122.21.755.755

Published: 2013

Journal Articles

Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay

Blood (2013) 122 (21): 230.

https://doi.org/10.1182/blood.V122.21.230.230

Published: 2013

Journal Articles

Overview Of The Genomic Landscape Of High Risk Diffuse Large B-Cell Lymphoma Using Targeted DNA and RNA Sequencing

Kai Wang, MD PhD, Michelle Nahas, PhD, Anthony R Mato, MD, MSCE, Amy L Donahue, MS, Jie He, PhD, Geoff A Otto, PhD, Doron Lipson, PhD, Roman Yelensky, PhD, Jeff Ross, MD, Phil Stephens, PhD, Kar Fai Chow, MD, Tania Zielonka, Pritish K. Bhattacharyya, MD, Ewelina Protomastro, BS, Tatyana Feldman, MD, Andrew L. Pecora, MD, Vincent Miller, MD, Andre Goy, MD

Blood (2013) 122 (21): 501.

https://doi.org/10.1182/blood.V122.21.501.501

Published: 2013

NARROW

CAR2.0 Therapy for the Management of Post-Transplantation Relapse of B-Cell Acute Lymphoblastic Leukemia

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

High-Throughput Mutational Profiling Of Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia Reveals Frequent Mutations In NRAS In JAK2 V617F-Negative Post-MPN AML

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms

Comprehensive Mutational Profiling In Myelodysplastic Syndromes Treated With Decitabine and Tretinoin

Patient Derived Xenograft (PDX) Models Faithfully Recapitulate The Genetic Composition Of Primary AML

Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma

Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay

Overview Of The Genomic Landscape Of High Risk Diffuse Large B-Cell Lymphoma Using Targeted DNA and RNA Sequencing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only